http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685371-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28a89f8dab024e02ae765d1273e716f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa9bf827d8743cb7b89f4187c0291cba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f7453f262061342a43659ae759b09b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b2e918b244b0b11e11cf099992b81f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_231f50e4b1d44f08188ba3f369bc28a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2009-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b859643ea694d2c29d0a5f3a7caebb85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91116b07028fa89aa268696627baf282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_218e68da8f3a6c03ffc87ec29f0c3369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91062e6d33a38de8c1182fb546f1dc6e
publicationDate 2014-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8685371-B2
titleOfInvention Agents for detecting and imaging cell death
abstract This invention relates to molecular imaging agents comprising an S78C mutant synaptotagmin I C2A domain. These agents may be useful in detecting or assessing cell death in vitro and in vivo, for example in tumors following cancer treatment.
priorityDate 2008-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03105814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006055855-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8506928-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID450233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128332710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129383430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129433588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID367929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128097093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129087132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128547714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129243198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13961087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128593154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128912572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10188072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129192845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128604602

Total number of triples: 52.